Insights and News Curated for Life Science Experts by Life Science Experts....

INSIGHTS HUB

As Life Sciences recruiting becomes more selective and AI has continued advancement, incorporating these technologies into recruitment...

In a landmark decision, the Federal Trade Commission (FTC) has voted 3-2 to approve the issuance of a final rule that could reshape the...

How automation has corrupted candidate attraction, and what can you as a Hiring Manger or Talent Acquisition Professional do to be more...

San Francisco, CA, December 26, 2024 (PRNewswire) -- AusperBio has raised $73 million in Series B funding to advance its lead therapy,...

Santa Cruz, CA, December 13, 2024 (Yahoo) -- Capstan Medical has raised $110 million in a Series C funding round led by Eclipse, with...

Philadelphia, December 4, 2024 (PRNewswire) -- Dr. Vatsala Naageshwaran, an accomplished biopharmaceutical leader, has been appointed...

South San Francisco, CA, December 18, 2024 (Business Wire) -- SiteOne Therapeutics has raised $100 million in Series C funding to...

San Diego, CA, December 12, 2024 (Business Wire) -- Pleno, Inc., a clinical and multi-omics diagnostics company, has appointed Dr. Vik...

North Chicago, IL and Madison, WI, December 13, 2024 (PRNewswire) -- AbbVie will acquire Nimble Therapeutics, gaining its lead oral...

Moderated by Colleen Burns , Fractional Chief Marketing & Growth Officer | CBM Group In an era defined by constant distraction, the...

Redwood City, CA, December 3, 2024 (Globe Newswire) -- Coherus is selling its UDENYCA franchise to Intas Pharmaceuticals for up to...

Chicago, December 3, 2024 (Globe Newswire) -- COUR Pharmaceuticals and Genentech have partnered to develop novel autoimmune disease...

Tampa, FL, December 4, 2024 (AccessWire) -- BioFuse Medical Technologies has announced significant leadership updates, appointing Rick...

Houston, TX, December 2, 2024 ( Business Wire ) -- Velentium has announced a leadership transition to support its continued growth,...

Warren, NJ, December 2, 2024 (Reuters) -- Novartis is acquiring PTC Therapeutics' Huntington’s disease drug, PTC518, for up to $2.9...